{
    "clinical_study": {
        "@rank": "95762", 
        "acronym": "ISAR-denerve", 
        "arm_group": [
            {
                "arm_group_label": "Medical therapy", 
                "arm_group_type": "No Intervention", 
                "description": "Best medical therapy using guideline recommended drugs in each disease state."
            }, 
            {
                "arm_group_label": "Catheter-based renal denervation", 
                "arm_group_type": "Experimental", 
                "description": "Renal denervation will be performed in the native renal arteries of patients after renal transplantation. Access side is the contralateral femoral artery."
            }
        ], 
        "brief_summary": {
            "textblock": "The study is aiming to document the safety and effectiveness of renal denervation in\n      patients after renal transplantation with hypertension. Catheter-based renal denervation\n      will be performed using CE marked, percutaneous Symplicity catheter."
        }, 
        "brief_title": "Impact of Sympathetic Renal Denervation- a Study in Patients After Renal Transplantation", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Chronic Kidney Disease", 
            "Renal Transplantation", 
            "Sympathetic Activity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient after renal transplantation (> 6 month) without resection of native kidneys\n\n          -  systolic blood pressure >=150 mmHg\n\n          -  on 3 or more antihypertensive medications\n\n          -  Individual is 18 years of age\n\n          -  Individual agrees to have all procedures performed, and is competent and  willing to\n             provide written, informed consent to participate in the registry.\n\n        Exclusion Criteria:\n\n          -  secondary causes and a white coat hypertension\n\n          -  renal artery abnormalities\n\n          -  eGFR < 45mL/min (MDRD)\n\n          -  angina\n\n          -  severe Aortic valve stenosis\n\n          -  Individual is pregnant, nursing or planning to be pregnant\n\n          -  other"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899456", 
            "org_study_id": "5548/12"
        }, 
        "intervention": {
            "arm_group_label": "Catheter-based renal denervation", 
            "intervention_name": "Catheter-based renal denervation", 
            "intervention_type": "Device", 
            "other_name": "Renal denervation with Symplicity Catheter Medtronic/Ardian"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Munich", 
                    "country": "Germany", 
                    "zip": "81675"
                }, 
                "name": "1. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Safety and Efficacy Study Investigating the Effects of Catheter-based Renal Denervation in Patients After Renal Transplantation", 
        "overall_official": {
            "affiliation": "1. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Unversit\u00e4t M\u00fcnchen", 
            "last_name": "Simon Schneider, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Office for Radiation Protection", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Effect on blood pressure including office, ABPM, and home-based measurements. Number of adverse events. Changes of antihypertensive medications. Effects on renal function assessed with glomerular filtration rate. Renovascular safety (renal artery stenosis) assessed by duplex ultrasound.", 
            "measure": "Safety and efficacy of renal denervation in patients after renal transplantation", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899456"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Technische Universit\u00e4t M\u00fcnchen", 
            "investigator_full_name": "Simon Schneider", 
            "investigator_title": "Simon Schneider, MD; 1.Medizinische Klinik und Poliklinik, Klinikum rechts der Isar", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Effects on sympathetic activity assessed by heart rate variability and post extrasystolic potentiation. Glucose metabolism and insulin resistance (fasting and during oGTT). Hospitalization rates (eg. hypertensive emergencies, heart failure, etc).", 
            "measure": "Effect of renal denervation in patients after renal transplantation on different organ systems.", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline to 6 month"
        }, 
        "source": "Technische Universit\u00e4t M\u00fcnchen", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Nephrology, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t M\u00fcnchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}